Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE3
20 participants
INTERVENTIONAL
2014-10-31
2015-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Local Insulin on Varicose Ulcers for Wound Healing
NCT04310280
A Study to Evaluate ENERGI-F703 GEL in Diabetic Foot Ulcer
NCT05930210
Effects of Pulsatile Intravenous (IV) Insulin on Wound Healing in Diabetics
NCT00967837
Plasma Activated Saline in Wound Treatment
NCT05924867
Topic Insulin Accelerates Wound Healing in Diabetes
NCT01295177
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Insulin
Half of the wound surface was treated daily with intermediate insulin. Allocation was randomized.
Insulin
Half of the wound surface was treated daily with 10 units of intermediate insulin.
Placebo
Half of the wound surface was treated daily with normal saline. Allocation was randomized.
Placebo
Half of the wound surface was treated daily with 0.1 cc of normal saline.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Insulin
Half of the wound surface was treated daily with 10 units of intermediate insulin.
Placebo
Half of the wound surface was treated daily with 0.1 cc of normal saline.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidad Autonoma de San Luis Potosí
OTHER
Hospital Central "Dr. Ignacio Morones Prieto"
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
MARIO AURELIO MARTÍNEZ-JIMÉNEZ
General Surgeon
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jorge Aguilar-García, MD
Role: STUDY_CHAIR
Hospital Central "Dr. Ignacio Morones Prieto"
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Central Dr. Ignacio Morones Prieto
San Luis Potosí City, San Luis Potosí, Mexico
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Martinez-Jimenez MA, Aguilar-Garcia J, Valdes-Rodriguez R, Metlich-Medlich MA, Dietsch LJP, Gaitan-Gaona FI, Kolosovas-Machuca ES, Gonzalez FJ, Sanchez-Aguilar JM. Local use of insulin in wounds of diabetic patients: higher temperature, fibrosis, and angiogenesis. Plast Reconstr Surg. 2013 Dec;132(6):1015e-1019e. doi: 10.1097/PRS.0b013e3182a806f0.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
71-13
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.